We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immunodiagnostic Systems Holdings Plc | LSE:IDH | London | Ordinary Share | GB00B01YZ052 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 378.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/5/2021 05:10 | cash offer by Perkin Elmer yesterday Isnt it all over? | cottlet | |
17/5/2021 10:22 | Syme 1p this time.Mega contact update inbound | 36jay | |
17/5/2021 09:49 | This is mega deal.Just a start. | 36jay | |
17/5/2021 09:48 | Huge uptrend and dirt cheap.100% by close looks very conservative | 36jay | |
17/5/2021 09:28 | Nice surprise. Doubled my money here and sold. Incredible lack of bb activity on this share, largely down to mgmt inertia and presumably not too many PIs. Mgmt no doubt will have done well from this and no doubt keeping all the great news till this is a done deal but I am happy for one. Just shows how undervalued tech companies are in London when suddenly the market can put a cap on its value double what it was a few days prior-with no 'apparent' change in it's circumstances. Hold loads of shares in companies like BVC, VEC, Fab etc which I feel (and hope) are in a similar position but not sure why tech companies actually bother to list here. | cumnor | |
01/4/2021 08:42 | A drop of 7.5% on no volume. Wowwwwww | mw16 | |
27/11/2020 16:00 | Quite understand your pov faz, it's been a serial disappointer. However I've decided to hang on; this could be the game changer. If the convenience of the card or cassette test gives it the edge then we are talking millions of tests and the margin must be £2 or £3 per test dropping through to the bottom line. Must go and lie down, that mushroom soup was stronger than I thought. | dozey3 | |
27/11/2020 14:43 | Because this share is so hard to sell I have used today's rise (and some patience) to rid myself of my holding. | faz | |
27/11/2020 11:28 | Let's see, this is the only UK company that offers Lateral flow antigen test. Testing will still be needed for a long time, especially of this type that doesn't need machines. It's all about sales, and who doesn't want a 15min test, especially for travellers and sports fans and players. Very cheap atm imo. No more waiting and self-isolation. | crosschris | |
27/11/2020 11:24 | The kits are not theirs. Looks like they're acting as a non-exclusive distributor. | wjccghcc | |
27/11/2020 10:19 | All these kits will be history once the vaccines roll out, not an investment here imo | ny boy | |
27/11/2020 08:23 | noce start ,also syme gradually starting to move up again Gradually ,hoping for a good strong day here at idh | bunz3 | |
27/11/2020 08:22 | Well very surprised ... Now they need to sell them now.. All very well building the car .. you have to sell it now. and you have to sell loads. That always seems to be the issue with this company. | undervaluedassets | |
27/11/2020 08:21 | like the buying volume here Today . | bunz3 | |
29/10/2020 10:35 | always the way ... The winner these days is a always a whale. which is the better investment:- Amazon or Dixons Carphone? Novacyt with a gazillion COVID test kits sold or IDH with a paltry £400,000 worth? Not difficult to spot the winner And the loser | undervaluedassets | |
26/10/2020 13:36 | It's the equivalent of a Barcelona scout watching Messi, Ronaldo and De Bruyne play at the age of 15 and deciding he doesn't want any of them. Novacyte, Avacta, Omega - doh! | wigwammer | |
26/10/2020 13:32 | They had years and years to do it. To consolidate the industry. Cash available. Inside knowledge of the sector. What the frick have they been doing all these years??!! | wigwammer | |
26/10/2020 13:31 | The most ridiculous thing is this management team have sat on £30m cash while companies like Novacyte and Avacta were trading at tiny market values. Where was the foresight to recognise the undervaluation of these technologies? Why didn't they consolidate their sector when they had the cash and these technologies were on "sitting duck" valuations? Dreadful. And then there's the Friday afternoon RNS timing..... amateur. | wigwammer | |
26/10/2020 12:38 | The problem is their covid test is clearly not selling While Novacyt test kits are going gangbusters. Donkey Versus racehorse. The net result You are backing Blackberry here as opposed Apple. Another thing .. The timing of the update quite shocking in my view. Am Out. | undervaluedassets | |
26/10/2020 11:45 | Sitting with close to 25 mill in cash and a rapid covid test in the making this could move up rapid as small free float iam in. | donmac101 | |
26/10/2020 11:11 | Just bought in here-with cash cushion, small mrkt cap by Covid standards for diagnostic companies and an expected bad half due to Covid should be upside from here, esp if any of their Covid stuff sells. | cumnor | |
26/10/2020 11:02 | Oh yeah, forgot, the majority of them buys | mw16 | |
26/10/2020 11:01 | Amazing that an so can be decimated on 35000 shares traded | mw16 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions